pSivida is a pharmaceutical company focused on the development of innovative miniaturized, sustained-release drug delivery products and technologies to treat serious, debilitating diseases of the eye that can lead to blindness. 
pSivida is focused on treatment of chronic diseases of the back of the eye utilizing its core technology systems, Durasert and BioSilicon. The injectable, sustained release micro-insert ILUVIEN for the treatment of chronic Diabetic Macula Edema (DME), licensed to Alimera Sciences, Inc., and utilizes the third generation of the Durasert technology. pSivida's two FDA-approved products, Retisert and Vitrasert, are implants that provide long-term, sustained drug delivery to treat two other chronic diseases of the retina.


Type
Public
HQ
Watertown, US
Founded
1987
Size (employees)
22 (est)
pSivida was founded in 1987 and is headquartered in Watertown, US
Report incorrect company information

pSivida Office Locations

pSivida has an office in Watertown
Watertown, US (HQ)
480 Pleasant St, Suite B300
Show all (1)
Report incorrect company information

pSivida Financials and Metrics

pSivida Financials

pSivida's revenue was reported to be $1.62 m in FY, 2016 which is a 93.9% decrease from the previous period.
USD

Revenue (Q2, 2018)

1.3 m

Net income (Q2, 2018)

(11.8 m)

EBIT (Q2, 2018)

(11.8 m)

Market capitalization (29-Mar-2018)

54.3 m

Cash (31-Dec-2017)

12.9 m
pSivida's current market capitalization is $54.3 m.
Annual
USDFY, 2014FY, 2015FY, 2016

Revenue

3.5 m26.6 m1.6 m

Revenue growth, %

665%(94%)

General and administrative expense

7.5 m8.1 m9 m

R&D expense

9.6 m12.1 m14.4 m
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q2, 2018

Revenue

597 k592 k2 m25.3 m521 k328 k466 m526 k324 k277 k6 m590 k1.3 m

General and administrative expense

1.8 m1.7 m1.9 m1.7 m1.9 m2 m2 b2 m2.3 m3.3 m2.9 m2.4 m5 m

R&D expense

2.5 m2.5 m2.3 m2.8 m2.8 m3.3 m3.5 b3.7 m3.1 m4.2 m3.2 m3.3 m8.1 m

Operating expense total

4.3 m4.1 m4.2 m4.5 m4.6 m5.4 m5.5 b5.8 m5.4 m7.5 m6.1 m5.8 m13.1 m
Annual
USDFY, 2014FY, 2015FY, 2016

Cash

15.3 m19.1 m15.3 m

Accounts Receivable

11.9 m

Inventories

547 k681 k483 k

Current Assets

19.3 m29.8 m30 m
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q2, 2018

Cash

14.5 m15.2 m18.6 m11.4 m29.8 m23 m14.1 m11.2 m24.9 m14.3 m11.7 m12.9 m12.9 m

Current Assets

19.1 m17.2 m22.5 m40.7 m37.3 m33.1 m25.2 m21.9 m34.3 m23.5 m18.5 m16.5 m13.6 m

PP&E

146 k133 k292 k261 k265 k280 k318 k311 k311 k257 k231 k241 k293 k

Total Assets

22.7 m20.8 m26 m43.7 m40.2 m35.7 m27.5 m24 m36.2 m24.9 m19.7 m17.5 m14.2 m
Annual
USDFY, 2014FY, 2015FY, 2016

Net Income

(13.4 m)6.3 m(21.5 m)

Depreciation and Amortization

139 k112 k152 k

Inventories

1.1 m(136 k)187 k

Accounts Payable

(213 k)292 k626 k
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q2, 2018

Net Income

(3.7 m)(3.5 m)(2.2 m)20.6 m(4.1 m)(5 m)(4.9 b)(5.2 m)(5 m)(7.2 m)(67 k)(5.1 m)(11.8 m)

Depreciation and Amortization

39 k83 k

Accounts Payable

(438 k)1.1 m384 k812 k893 k303 k571 k1 m1.1 m741 k(1.5 m)

Cash From Operating Activities

(3.8 m)(11 m)
USDY, 2017

Revenue/Employee

59.9 k

Financial Leverage

1.4 x
Show all financial metrics
Report incorrect company information

pSivida News and Updates

Ocular Drug Delivery Market: Manufacturers Collaborating with Hospitals to Bolster Positions

Ocular Drug Delivery Technology Market report categorize the global market by Technology (Topical, Ocular Inserts, Iontophoresis, Intraocular Implants and In Situ Gel & Punctal Plugs), Disease Type (Glaucoma, Diabetic Retinopathy, Macular Degeneration), End User & Geography Posted via Indust…

Uveitis Treatment Market is expected to expand at a CAGR of 7.3% from 2014 to 2020

Rising prevalence of eye syndromes are estimated to contribute significantly towards growth of the market in the span of next six years. Posted via Industry Today. Follow us on Twitter @IndustryToday
Report incorrect company information